97 related articles for article (PubMed ID: 16280261)
1. A LC-MS/MS method to quantify the novel cholesterol lowering drug ezetimibe in human serum, urine and feces in healthy subjects genotyped for SLCO1B1.
Oswald S; Scheuch E; Cascorbi I; Siegmund W
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(1):143-50. PubMed ID: 16280261
[TBL] [Abstract][Full Text] [Related]
2. Disposition and sterol-lowering effect of ezetimibe are influenced by single-dose coadministration of rifampin, an inhibitor of multidrug transport proteins.
Oswald S; Giessmann T; Luetjohann D; Wegner D; Rosskopf D; Weitschies W; Siegmund W
Clin Pharmacol Ther; 2006 Nov; 80(5):477-85. PubMed ID: 17112804
[TBL] [Abstract][Full Text] [Related]
3. Liquid chromatography-negative ion electrospray tandem mass spectrometry method for the quantification of ezetimibe in human plasma.
Li S; Liu G; Jia J; Li X; Yu C
J Pharm Biomed Anal; 2006 Mar; 40(4):987-92. PubMed ID: 16242881
[TBL] [Abstract][Full Text] [Related]
4. Disposition of the cholesterol absorption inhibitor ezetimibe in mdr1a/b (-/-) mice.
Oswald S; Koll C; Siegmund W
J Pharm Sci; 2007 Dec; 96(12):3478-84. PubMed ID: 17828742
[TBL] [Abstract][Full Text] [Related]
5. Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects.
Patrick JE; Kosoglou T; Stauber KL; Alton KB; Maxwell SE; Zhu Y; Statkevich P; Iannucci R; Chowdhury S; Affrime M; Cayen MN
Drug Metab Dispos; 2002 Apr; 30(4):430-7. PubMed ID: 11901097
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of ezetimibe and its glucuronide metabolite in human plasma by solid phase extraction and liquid chromatography-tandem mass spectrometry.
Guo L; Wang MM; He M; Qiu FR; Jiang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 986-987():108-14. PubMed ID: 25725321
[TBL] [Abstract][Full Text] [Related]
7. Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1.
Oswald S; König J; Lütjohann D; Giessmann T; Kroemer HK; Rimmbach C; Rosskopf D; Fromm MF; Siegmund W
Pharmacogenet Genomics; 2008 Jul; 18(7):559-68. PubMed ID: 18551036
[TBL] [Abstract][Full Text] [Related]
8. Synergistic influence of Abcb1 and Abcc2 on disposition and sterol lowering effects of ezetimibe in rats.
Oswald S; May K; Rosin J; Lütjohann D; Siegmund W
J Pharm Sci; 2010 Jan; 99(1):422-9. PubMed ID: 19504475
[TBL] [Abstract][Full Text] [Related]
9. Disposition and sterol-lowering effect of ezetimibe in multidrug resistance-associated protein 2-deficient rats.
Oswald S; Westrup S; Grube M; Kroemer HK; Weitschies W; Siegmund W
J Pharmacol Exp Ther; 2006 Sep; 318(3):1293-9. PubMed ID: 16772539
[TBL] [Abstract][Full Text] [Related]
10. LC-MS-MS simultaneous determination of atorvastatin and ezetimibe in human plasma.
El-Bagary RI; Elkady EF; El-Sherif ZA; Kadry AM
J Chromatogr Sci; 2014 Sep; 52(8):773-80. PubMed ID: 23885041
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a liquid chromatography/ mass spectrometry method for the simultaneous quantitation of rosuvastatin and ezetimibe in human plasma.
Varghese SJ; Ravi TK
J AOAC Int; 2013; 96(2):307-12. PubMed ID: 23767355
[TBL] [Abstract][Full Text] [Related]
12. Application of one-step liquid chromatography-electrospray tandem MS/MS and collision-induced dissociation to quantification of ezetimibe and identification of its glucuronated metabolite in human serum: A pharmacokinetic study.
Bahrami G; Mohammadi B; Khatabi PM; Farzaei MH; Majnooni MB; Bahoosh SR
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(28):2789-95. PubMed ID: 20829132
[TBL] [Abstract][Full Text] [Related]
13. SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin.
Niemi M; Pasanen MK; Neuvonen PJ
Clin Pharmacol Ther; 2006 Oct; 80(4):356-66. PubMed ID: 17015053
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic interaction between ezetimibe and rosuvastatin.
Kosoglou T; Statkevich P; Yang B; Suresh R; Zhu Y; Boutros T; Maxwell SE; Tiessen R; Cutler DL
Curr Med Res Opin; 2004 Aug; 20(8):1185-95. PubMed ID: 15324521
[TBL] [Abstract][Full Text] [Related]
15. Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans.
Oswald S; Haenisch S; Fricke C; Sudhop T; Remmler C; Giessmann T; Jedlitschky G; Adam U; Dazert E; Warzok R; Wacke W; Cascorbi I; Kroemer HK; Weitschies W; von Bergmann K; Siegmund W
Clin Pharmacol Ther; 2006 Mar; 79(3):206-17. PubMed ID: 16513445
[TBL] [Abstract][Full Text] [Related]
16. Effects of UDP-glucuronosyltransferase polymorphisms on the pharmacokinetics of ezetimibe in healthy subjects.
Bae JW; Choi CI; Lee JH; Jang CG; Chung MW; Lee SY
Eur J Clin Pharmacol; 2011 Jan; 67(1):39-45. PubMed ID: 20865252
[TBL] [Abstract][Full Text] [Related]
17. Impact of efavirenz on intestinal metabolism and transport: insights from an interaction study with ezetimibe in healthy volunteers.
Oswald S; Meyer zu Schwabedissen HE; Nassif A; Modess C; Desta Z; Ogburn ET; Mostertz J; Keiser M; Jia J; Hubeny A; Ulrich A; Runge D; Marinova M; Lütjohann D; Kroemer HK; Siegmund W
Clin Pharmacol Ther; 2012 Mar; 91(3):506-13. PubMed ID: 22297387
[TBL] [Abstract][Full Text] [Related]
18. An improved liquid chromatography/tandem mass spectrometry method for the determination of 8-oxo-7,8-dihydro-2'-deoxyguanosine in DNA samples using immunoaffinity column purification.
Singh R; McEwan M; Lamb JH; Santella RM; Farmer PB
Rapid Commun Mass Spectrom; 2003; 17(2):126-34. PubMed ID: 12512091
[TBL] [Abstract][Full Text] [Related]
19. A LC-MS/MS method to evaluate the hepatic uptake of the liver-specific magnetic resonance imaging contrast agent gadoxetate (Gd-EOB-DTPA) in vitro and in humans.
Jia J; Keiser M; Nassif A; Siegmund W; Oswald S
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Apr; 891-892():20-6. PubMed ID: 22391331
[TBL] [Abstract][Full Text] [Related]
20. Determination of a novel nonfluorinated quinolone, nemonoxacin, in human feces and its glucuronide conjugate in human urine and feces by high-performance liquid chromatography-triple quadrupole mass spectrometry.
He G; Guo B; Yu J; Zhang J; Wu X; Cao G; Shi Y; Tsai CY
Biomed Chromatogr; 2015 May; 29(5):739-48. PubMed ID: 25322721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
